Company: INDP
Filing Date: 2025-01-14
Form Type: 8-K
Source: 0001493152-25-002145
Chunk: 2

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-01-14
Form: 8-K
Item: Item 1.01
Chunk 2
---
 prior to
registration or qualification under the securities laws of any such state.

Warning
Concerning Forward Looking Statements

This
Form 8-K contains statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995 and other securities laws. These forward looking statements are based upon the Company’s present intent, beliefs or
expectations, but forward looking statements are not guaranteed to occur and may not occur for various reasons, including some reasons
which are beyond the Company’s control. For example, this Form 8-K states that the private placement is expected to close on or
about January 15, 2025. In fact, the closing of the private placement is subject to various conditions and contingencies as are customary
in securities purchase agreements in the United States. If these conditions are not satisfied or the specified contingencies do not occur,
this offering may not close. For this reason, among others, you should not place undue reliance upon the Company’s forward looking
statements. Except as required by law, the Company undertakes no obligation to revise or update any forward looking statements in order
to reflect any event or circumstance that may arise after the date of this Form 8-K.